Related Experiment Videos
[Portasystemic shunt--our twenty years experience]
M Uravić1, A Depolo, R Dobrila-Dintinjana
1Department of Digestive Surgery, Surgical Clinic, University Hospital Rijeka, Croatia, The Netherlands.
Zentralblatt Fur Chirurgie
|December 12, 2002
Summary
Selective shunts significantly improved outcomes for patients with chronic liver disease and variceal bleeding, reducing mortality and rebleeding. This surgical approach offers a vital option when other treatments are unavailable.
Area of Science:
- Gastroenterology and Hepatology
- Surgical Innovation
- Clinical Outcomes Research
Background:
- Chronic liver disease frequently leads to gastroesophageal varices and bleeding.
- Portasystemic shunt (PSO) surgery has been used to manage variceal bleeding.
- Evolving surgical techniques aim to improve patient outcomes.
Purpose of the Study:
- To evaluate the long-term efficacy and safety of portasystemic shunt surgery.
- To compare outcomes between different eras of surgical practice.
- To assess the impact of surgical technique on patient survival and complications.
Main Methods:
- A retrospective analysis of 90 portasystemic shunt operations performed between 1980 and 1998.
- Patients were divided into two groups based on the surgical period (1980-1988 and 1988-1998).
- Comparison of early and late mortality, encephalopathy rates, and variceal rebleeding between groups.
Main Results:
- The second group (1988-1998) demonstrated significantly lower early mortality (9% vs. 16%) and late mortality (6% vs. 35%).
- Encephalopathy rates decreased from 43% to 12% in the later group.
- Variceal rebleeding rates were reduced from 10% to 6% in the second group.
Conclusions:
- Selective shunts, like the distal splenorenal shunt, are superior to standard portasystemic shunts.
- Portasystemic shunt surgery remains a critical life-saving option for variceal bleeding when advanced treatments are inaccessible.
- Surgical technique advancements have led to improved patient survival and reduced complications.